文献速递儿科与产科急症重症综合管理与镇静镇痛

二甲双胍延长早产性子痫前期妊娠:随机双盲安慰剂对照试验

Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trial.
PubMed 文献 · BMJ · 2021-09-22
一句话结论早产性子痫前期期待治疗中,缓释二甲双胍3g/日可延长妊娠,但主要终点未达统计学显著,需进一步试验。

该随机双盲安慰剂对照试验在南非开普敦转诊医院纳入180例26+0至31+6周早产性子痫前期期待治疗孕妇,随机接受口服缓释二甲双胍3g/日(分次)或安慰剂至分娩。主要终点妊娠延长中位数差异7.6天(几何均数比1.39,95%CI 0.99-1.95;P=0.057),未达统计学显著;持续用药者中位差异9.6天(1.67,1.16-2.42),全剂量者差异11.5天(1.85,1.14-2.88)。母胎新生儿复合结局及生物标志物无差异,无严重不良事件,腹泻更常见。

要点

  • 早产性子痫前期26+0至31+6周期待治疗孕妇,口服缓释二甲双胍3g/日分次至分娩,主要终点妊娠延长未达显著(P=0.057)。
  • 持续用药者中位妊娠延长17.5天 vs 安慰剂7.9天,差异9.6天(几何均数比1.67,95%CI 1.16-2.42)。
  • 全剂量用药者中位延长16.3天 vs 4.8天,差异11.5天(几何均数比1.85,95%CI 1.14-2.88)。
  • 母胎新生儿复合结局及sFlt-1、PlGF、sEng浓度无差异;无严重不良事件,腹泻更常见。
  • 二甲双胍组出生体重非显著增加,新生儿 nursery 住院时间缩短。

适用人群与场景

  • 26+0至31+6周妊娠的早产性子痫前期孕妇,在南非开普敦转诊医院接受期待治疗。
  • 排除标准原文未提及。

诊断标准与关键阈值

  • 早产性子痫前期诊断标准原文未提及。
  • 妊娠孕周范围26+0至31+6周为纳入条件。

处置流程与药物剂量

  • 口服缓释二甲双胍3g/日,分次给药,直至分娩;对照为安慰剂。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 随机双盲安慰剂对照试验,单中心,180例(二甲双胍90例,安慰剂90例)。
  • 主要终点妊娠延长:中位17.7天 vs 10.1天,中位差异7.6天(几何均数比1.39,95%CI 0.99-1.95;P=0.057)。
  • 持续用药者:中位17.5天 vs 7.9天,差异9.6天(几何均数比1.67,95%CI 1.16-2.42)。
  • 全剂量者:中位16.3天 vs 4.8天,差异11.5天(几何均数比1.85,95%CI 1.14-2.88)。
  • 母胎新生儿复合结局及sFlt-1、PlGF、sEng浓度无差异;无严重不良事件,腹泻更常见;出生体重非显著增加,新生儿 nursery 住院时间缩短。

证据类型、等级与局限

  • 证据类型:随机双盲安慰剂对照试验。
  • 局限:单中心、样本量180例、主要终点未达统计学显著、需进一步试验。

对床旁实践的改变

  • 该试验提示缓释二甲双胍可能延长早产性子痫前期妊娠,但主要终点未达显著,不能作为常规推荐。
  • 适用人群为26+0至31+6周早产性子痫前期期待治疗孕妇;不适用人群原文未提及。
  • 常见陷阱:主要终点P=0.057未达显著,亚组分析(持续用药、全剂量)结果需谨慎解读。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate whether extended release metformin could be used to prolong gestation in women being expectantly managed for preterm pre-eclampsia.

DESIGN: Randomised, double blind, placebo controlled trial.

SETTING: Referral hospital in Cape Town, South Africa.

PARTICIPANTS: 180 women with preterm pre-eclampsia between 26+0 to 31+6 weeks' gestation undergoing expectant management: 90 were randomised to extended release metformin and 90 to placebo.

INTERVENTION: 3 g of oral extended release metformin or placebo daily, in divided doses, until delivery.

MAIN OUTCOME MEASURE: The primary outcome was prolongation of gestation.

RESULTS: Of 180 participants, one woman delivered before taking any trial drug. The median time from randomisation to delivery was 17.7 days (interquartile range 5.4-29.4 days; n=89) in the metformin arm and 10.1 (3.7-24.1; n=90) days in the placebo arm, a median difference of 7.6 days (geometric mean ratio 1.39, 95% confidence interval 0.99 to 1.95; P=0.057). Among those who continued to take the trial drug at any dose, the median prolongation of gestation in the metformin arm was 17.5 (interquartile range 5.4-28.7; n=76) days compared with 7.9 (3.0-22.2; n=74) days in the placebo arm, a median difference of 9.6 days (geometric mean ratio 1.67, 95% confidence interval 1.16 to 2.42). Among those who took the full dosage, the median prolongation of gestation in the metformin arm was 16.3 (interquartile range 4.8-28.8; n=40) days compared with 4.8 (2.5-15.4; n=61) days in the placebo arm, a median difference of 11.5 days (geometric mean ratio 1.85, 95% confidence interval 1.14 to 2.88). Composite maternal, fetal, and neonatal outcomes and circulating concentrations of soluble fms-like tyrosine kinase-1, placental growth factor, and soluble endoglin did not differ. In the metformin arm, birth weight increased non-significantly and length of stay decreased in the neonatal nursery. No serious adverse events related to trial drugs were observed, although diarrhoea was more common in the metformin arm.

CONCLUSIONS: This trial suggests that extended release metformin can prolong gestation in women with preterm pre-eclampsia, although further trials are needed. It provides proof of concept that treatment of preterm pre-eclampsia is possible.

TRIAL REGISTRATION: Pan African Clinical Trial Registry PACTR201608001752102 https://pactr.samrc.ac.za/.

来源:BMJ,查看原文。版权归原作者所有。

参考来源

  1. Cluver CA, Hiscock R, Decloedt EH, et al. Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trial. BMJ. 2021. PMID: 34551918. doi:10.1136/bmj.n2103

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。